Clinical Trials Logo

Clinical Trial Summary

A block-randomized, double-blind, placebo-controlled, single-dose escalating, phase I clinical trial to evaluate the safety, tolerability and pharmacokinetics of YHB1411-2 in healthy male volunteers


Clinical Trial Description

First in human Study ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01525147
Study type Interventional
Source Yuhan Corporation
Contact
Status Completed
Phase Phase 1
Start date December 2011
Completion date November 2013

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03685110 - CoreHip - Post Market Clinical Follow-Up Study
Recruiting NCT04485325 - Capability of Tofacitinib or Etanercept to Accelerate Tapering of NSAID and Treat-to-target Guided De-escalation of Corticosteroids in RA Patients Phase 4
Not yet recruiting NCT02020668 - Efficacy of Physiotherapy on the Health and Quality of Life of the Rheumatic Patient Phase 2
Recruiting NCT05007340 - ILD-SARDs Registry and Biorepository
Completed NCT05291130 - AESCULAP® Plasmafit® Cementless Acetabular System With Vitelene® Vitamin E Stabilized Highly Crosslinked Polyethylene
Active, not recruiting NCT04255966 - Plasmafit® Revision Structan® Hip Endoprosthesis Cup